I was trying to get some clarity as to why Patters

Quote:

---

I was trying to get some clarity as to why Pattersons was invalid. Was it timing, too broad (claiming to use any CCR5 inhibitor), the fact that he did some of the work while under contract with CYDY so he can't claim it as his.

---

Our patent was filed first.

Quote:

---

Does that also mean our disease specific patents may also not be enforceable if Patterson's is not.

---

A very broad patent may not be enforceable like "all CCR5 antagonists affecting a disease are under our patent". Every CCR5 antagonist acts slightly differently on each disease state. Your patent has to be specific on how it works. Patterson had an earlier Covid-19 patent which covered all CCR5 antagonists (including leronlimab) which could be challenged. But he later filed the one skezan linked that is specific to maraviroc. So our patents are enforceable.

Quote:

---

The counter is how do you keep drug prices in check without competition which these patents hinder.

---

That's why patents have an expiration of 20 years for drugs.